> Vical has shifted focus to its developmental vaccines after its melanoma immunotherapy failed Phase III. Piece
> Australian vaccine maker CSL posted a 19% rise in annual net profits to hit a record high of $1.2 billion. News
> Researchers have generated an Ad5 vector that is unaffected by neutralizing antibodies in mice. Abstract
> Cedars-Sinai Medical Center is running a Phase I trial to see if Copaxone can help Alzheimer's patients by stimulating immune cells. Release
> Researchers in Singapore have posted promising preclinical results for a dengue fever vaccine. Article